National Center for Research Resources; Notice of Closed Meetings, 75440 [E8-29272]
Download as PDF
75440
Federal Register / Vol. 73, No. 239 / Thursday, December 11, 2008 / Notices
manufacturer’s assistance, information
on video conferencing and electronic
submissions, Mammography Matters,
and other device-oriented information.
The CDRH Web site may be accessed at
https://www.fda.gov/cdrh. A search
capability for all CDRH guidance
documents is available at https://
www.fda.gov/cdrh/guidance.html.
Guidance documents are also available
on the CBER Internet site at https://
www.fda.gov/cber/guidelines.htm or on
the Division of Dockets Management
Internet site at https://
www.regulations.gov.
IV. Paperwork Reduction Act of 1995
This guidance refers to previously
approved collections of information
found in FDA regulations. These
collections of information are subject to
review by the Office of Management and
Budget (OMB) under the Paperwork
Reduction Act of 1995 (the PRA) (44
U.S.C. 3501–3520). The information
collection provisions in 21 CFR part
814, subpart B (Premarket Approval
Applications (PMAs)) in this guidance
have been approved under OMB control
number 0910–0231. This approval
expires November 30, 2010.
V. Comments
mstockstill on PROD1PC66 with NOTICES
Interested persons may submit to the
Division of Dockets Management (see
ADDRESSES) written or electronic
comments regarding this document.
Submit a single copy of electronic
comments or two paper copies of any
mailed comments, except that
individuals may submit one paper copy.
Comments are to be identified with the
docket number found in brackets in the
heading of this document. Received
comments may be seen in the Division
of Dockets Management between 9 a.m.
and 4 p.m., Monday through Friday.
Please note that on January 15, 2008,
the FDA Division of Dockets
Management Web site transitioned to
the Federal Dockets Management
System (FDMS). FDMS is a
Government-wide, electronic docket
management system. Electronic
comments or submissions will be
accepted by FDA only through FDMS at
https://www.regulations.gov.
Dated: December 5, 2008.
Jeffrey Shuren,
Associate Commissioner for Policy and
Planning.
[FR Doc. E8–29330 Filed 12–11–08; 8:45 am]
BILLING CODE 4160–01–S
VerDate Aug<31>2005
17:27 Dec 10, 2008
Jkt 217001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Research
Resources; Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Research Resources Special Emphasis Panel
CTSA 1.
Date: February 10–11, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Washington DC/Rockville
Hotel, Executive Meeting Center, 1750
Rockville Pike, Rockville, MD 20852.
Contact Person: Mohan Viswanathan, PhD,
Deputy Director, Office of Review, National
Center for Research Resources, National
Institutes of Health, 6701 Democracy Blvd.,
Dem. 1, Room 1084, MSC 4874, Bethesda,
MD 20892–4874, 301–435–0829,
mv10f@nih.gov.
Name of Committee: National Center for
Research Resources Special Emphasis Panel;
CTSA–2.
Date: February 18–19, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Washington DC /Rockville
Hotel, Executive Meeting Center, 1750
Rockville Pike, Rockville, MD 20852.
Contact Person: Mohan Viswanathan, PhD,
Deputy Director, Office of Review, National
Center for Research Resources, National
Institutes of Health, 6701 Democracy Blvd.,
Dem. 1, Room 1084, MSC 4874, Bethesda,
MD 20892–4874, 301–435–0829,
mv10f@nih.gov.
Name of Committee: National Center for
Research Resources Special Emphasis Panel
RCMI–COBRE.
Date: February 25–26, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Wash. DC/Rockville
Executive Meeting Center, 1750 Rockville
Pike, Rockville, MD 20852.
Contact Person: Steven Birken, PhD,
Scientific Revew Officer, Office of Review,
National Center for Research Resources, 1
PO 00000
Frm 00057
Fmt 4703
Sfmt 4703
Democracy Plaza, Room 1078, 6701
Democracy Blvd., Bethesda, MD 20892, 301–
435–0815, birkens@mail.nih.gov.
Name of Committee: National Center for
Research Resources Special Emphasis Panel;
RCMI Infrastructures for Clinical and
Translational Research (RCTR).
Date: March 4, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda Marriott Suites, 6711
Democracy Boulevard, Bethesda, MD 20817.
Contact Person: Carol Lambert, PhD,
Scientific Review Officer, Office of Review,
National Center for Research Resources,
National Institute of Health, 6701 Democracy
Boulevard, 1 Democracy Plaza, Room 1076,
Bethesda, MD 20892–4874, (301) 435–0814,
lambert@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research; 93.371, Biomedical
Technology; 93.389, Research Infrastructure,
93.306, 93.333, National Institutes of Health,
HHS)
Dated: December 4, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E8–29272 Filed 12–10–08; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Research Scientist Development Awards.
Date: December 18, 2008.
Time: 8:30 a.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Westin Arlington Gateway, 801
N. Glebe Road, Arlington, VA 22203.
Contact Person: Mark Roltsch, PhD,
Scientific Review Administrator, Review
Branch/DERA, National Heart, Lung, and
E:\FR\FM\11DEN1.SGM
11DEN1
Agencies
[Federal Register Volume 73, Number 239 (Thursday, December 11, 2008)]
[Notices]
[Page 75440]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-29272]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Center for Research Resources; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Center for Research Resources
Special Emphasis Panel CTSA 1.
Date: February 10-11, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Hilton Washington DC/Rockville Hotel, Executive Meeting
Center, 1750 Rockville Pike, Rockville, MD 20852.
Contact Person: Mohan Viswanathan, PhD, Deputy Director, Office
of Review, National Center for Research Resources, National
Institutes of Health, 6701 Democracy Blvd., Dem. 1, Room 1084, MSC
4874, Bethesda, MD 20892-4874, 301-435-0829, mv10f@nih.gov.
Name of Committee: National Center for Research Resources
Special Emphasis Panel; CTSA-2.
Date: February 18-19, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Hilton Washington DC /Rockville Hotel, Executive Meeting
Center, 1750 Rockville Pike, Rockville, MD 20852.
Contact Person: Mohan Viswanathan, PhD, Deputy Director, Office
of Review, National Center for Research Resources, National
Institutes of Health, 6701 Democracy Blvd., Dem. 1, Room 1084, MSC
4874, Bethesda, MD 20892-4874, 301-435-0829, mv10f@nih.gov.
Name of Committee: National Center for Research Resources
Special Emphasis Panel RCMI-COBRE.
Date: February 25-26, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Hilton Wash. DC/Rockville Executive Meeting Center, 1750
Rockville Pike, Rockville, MD 20852.
Contact Person: Steven Birken, PhD, Scientific Revew Officer,
Office of Review, National Center for Research Resources, 1
Democracy Plaza, Room 1078, 6701 Democracy Blvd., Bethesda, MD
20892, 301-435-0815, birkens@mail.nih.gov.
Name of Committee: National Center for Research Resources
Special Emphasis Panel; RCMI Infrastructures for Clinical and
Translational Research (RCTR).
Date: March 4, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Bethesda Marriott Suites, 6711 Democracy Boulevard,
Bethesda, MD 20817.
Contact Person: Carol Lambert, PhD, Scientific Review Officer,
Office of Review, National Center for Research Resources, National
Institute of Health, 6701 Democracy Boulevard, 1 Democracy Plaza,
Room 1076, Bethesda, MD 20892-4874, (301) 435-0814,
lambert@mail.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research; 93.371, Biomedical
Technology; 93.389, Research Infrastructure, 93.306, 93.333,
National Institutes of Health, HHS)
Dated: December 4, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E8-29272 Filed 12-10-08; 8:45 am]
BILLING CODE 4140-01-P